Head of Business Development – Global Biopharma Partnering

Job Title: Head of Business Development – Global Biopharma Partnering

Reports to: Chief Executive Officer

FLSA: Exempt

Location: Remote (San Diego, CA or San Francisco Bay Area, CA preferred)

Clear Note Health is an early cancer detection company focused on the development and commercialization of non‑invasive epigenomic tests to detect cancer through a standard blood draw, earlier than existing methods and when the disease is still treatable. Leveraging its novel liquid biopsy technology, Clear Note Health is initially focused on high‑mortality cancers with the greatest need for early detection, starting with pancreatic and certain women’s cancers.

The Head of Business Development – Global Biopharma Partnering is a key leadership role at Clear Note Health, responsible for driving revenue growth through strategic biopharma partnerships and collaborations leveraging our Virtuoso Epigenomics Platform. This individual working closely with our scientific leadership will build, manage and deepen partnerships with pharmaceutical and biotechnology companies, shape our biopharma data solutions offerings, secure new projects and exceed revenue targets.

The ideal candidate will possess deep knowledge of the biopharma landscape, particularly in oncology and the technologies used to support advanced R&D in the areas of drug development, diagnostics, genomics, and data solutions, and will leverage their experience and network to drive growth for the organization.

• Strategic Partnerships: Identify, develop, negotiate and manage partnerships with biopharmaceutical companies for both R&D and commercial opportunities. Drive revenue growth by creating, cultivating and building strong relationships with biopharma partners.
• Academic Engagement & Thought Leadership: Establish and foster connections with key academic experts involved in research collaborations with biopharma companies. Leverage these relationships to drive new business and enhance Clear Note Health’s positioning within the industry.
• Tailored Solutions Development: Collaborate with internal scientific, product development and medical teams to understand biopharma clients’ clinical questions, deliver customized data solutions to meet their research and clinical needs such as therapy response monitoring, patient selection, biomarker discovery, and recurrence detection. Establish a vision and pipeline of projects within the client’s development pathway for a long‑lasting book of business.
• Business Development Leadership: Manage the end‑to‑end BD process in collaboration with cross‑functional team members such as marketing, lab operations, biopharma development and finance from lead generation, follow‑up, proposal development, and securing contract approval, achieving favourable terms for both parties to enable long‑term, profitable partnerships.
• Cross‑functional
  
  Collaboration:
  
  Work closely with teams across biopharma development, R&D, laboratory operations, bioinformatics, information technology, legal, medical affairs, marketing and finance to enable successful acquisition, execution and delivery of customized solutions to support driving repeat business.
• Optimize Bio Pharma Offerings: Act as a voice of the Bio Pharma customer and help identify new use cases and optimise Clear Note Health’s Bio Pharma Data Solutions offerings based on client needs, market trends and competitive positioning.
• Industry Representation: Act as an external face of the organization, attending industry events and oncology conferences to promote Clear Note’s services, strengthen existing relationships, and foster new ones.
• Financial Forecasting: Work with finance and biopharma development to forecast revenue and take accountability for business results. Communicate with executive management and board members on strategy, execution and results.

• Put Patients First: Prioritise future patient impact by delivering high‑quality solutions to clients quickly and with purpose.
• Redefine the Possible: Innovate and take calculated risks to discover and implement new ideas that are designed to improve patient outcomes.
• Together We Win: Collaborate across…